Kanavig

Moxifloxacin Hydrochloride, the active ingredient in Kanavig, is a fluoroquinolone antibiotic presented as a 0.5% w/v ophthalmic solution for ocular (topical eye drops) use. It treats bacterial eye infections such as bacterial conjunctivitis, bacterial keratitis and blepharitis in patients requiring antibiotic therapy.

GNH USA supplies Kanavig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Kanavig (moxifloxacin hydrochloride) is a fluoroquinolone ophthalmic antibiotic used to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load, relieving redness, discharge and irritation. - Bacterial keratitis: eradicates causative bacteria, promoting corneal healing and preventing scarring. - Blepharitis: controls bacterial overgrowth on the eyelid margin, improving symptoms and reducing recurrence.

Kanavig may cause ocular adverse reactions, ranging from mild irritation to rare serious events.

Common Side Effects: - Stinging or burning: transient discomfort upon instillation. - Redness: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Corneal ulceration: progressive corneal damage. - Anterior uveitis: inflammation of the anterior chamber. - Severe allergic reaction: swelling, itching, or rash around the eye.

Before using Kanavig, consider the following precautions to ensure safe and effective therapy.

- Indication confirmation: ensure a bacterial eye infection is diagnosed before treatment. - Contact lens use: remove lenses prior to instillation and wait before reinserting. - Systemic absorption: avoid excessive dosing; monitor for systemic fluoroquinolone effects. - Pregnancy and lactation: safety not established; use only if benefits outweigh potential risks. - Allergic history: assess for hypersensitivity to fluoroquinolones or any formulation component. - Store at room temperature: keep in the original container, protect from light and moisture.

Kanavig can interact with other medications; awareness of these interactions helps minimize risks.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent systemic use may increase risk of tendon rupture. - Anticholinergic eye drops: may reduce the antibacterial efficacy of moxifloxacin. - Strong CYP450 inhibitors: may alter systemic exposure despite minimal ocular absorption.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may affect corneal healing. - Corticosteroid eye drops: monitor for delayed resolution of infection. - Other topical antibiotics: avoid overlapping therapy to reduce resistance development.